DENVER INVESTMENT ADVISORS LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 117 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
DENVER INVESTMENT ADVISORS LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$68,000
+4.6%
10,111
-10.2%
0.00%0.0%
Q3 2015$65,000
-31.6%
11,258
-3.3%
0.00%
-25.0%
Q2 2015$95,000
-21.5%
11,646
-21.4%
0.00%0.0%
Q1 2015$121,000
-12.9%
14,826
-2.1%
0.00%0.0%
Q4 2014$139,00015,1400.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders